Related Experiment Videos
Association between injection practices and duration of injection among recently initiated injection drug users
Meredith Becker Buxton1, David Vlahov, Steffanie A Strathdee
1Center for Urban Epidemiological Studies, New York Academy of Medicine, New York City, NY 10029-5293, USA. meredith.buxton@ucsfmedctr.org
Background:
Earlier studies suggest higher infection risk among recently initiated injection drug users (IDUs) than more experienced users. Whether IDUs' risky injection practices rise progressively with duration of injection or frequency of practices is higher near initiation and then taper remains an open question.
Methods:
Recently initiated IDUs were street recruited and interviewed between 1997 and 1999 as part of a multisite cohort study in five US urban cities. Recent risky injection practices (injecting with others and injecting on average more now) were examined across three cross-sections defined by duration of injection: 0-1 year, 2-3 years, and 4-6 years.
Results:
The IDU groups of <2 years duration (n = 691) and 2-3 years duration (n = 697) had higher odds than the 4-6 year group (n = 520) of reporting injecting with others (Odds Ratio, OR = 1.52, and OR = 1.47, respectively) and injecting on average more now (OR = 1.44 and OR = 1.44, respectively). The associations remained after multivariate adjustment for demographic variables.
Conclusions:
These data on recently initiated IDUs suggest that risky injection practices were more frequent earlier than later within the first 6 years of initiation, emphasizing that outreach prevention needs to identify and intervene with IDUs early.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...